Animal study to validate effects of ACOT1 silencing in Non-alcoholic Fatty Liver Disease (NAFLD)

ABSTRACT: 6-8-week-old male C57BL/6 were divided into 2 groups after 12 weeks on the HFD diet, and tail vein injections of an Adenoviral vector containing Ad-GFP-U6-scramble-shRNA or Ad-GFP-U6-m-ACOT1-shRNA at 1x109 PFU were performed weekly for 6 weeks (Vector Biolabs)

ORGANISM(S): Mus musculus

PROVIDER: GSE175426 | GEO | 2021/05/25

REPOSITORIES: GEO